Valneva SE (EPA:VLA)
France · Delayed Price · Currency is EUR 4.750
+0.162 (3.53%)
At close: Feb 20, 2026
Valneva SE Employees
Valneva SE had 700 employees as of June 30, 2025.
Employees
700
Change
n/a
Growth
n/a
Revenue / Employee
€252,331
Profits / Employee
€143,282
Market Cap
825.33M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 700 | - | - |
| Dec 31, 2024 | 713 | 37 | 5.47% |
| Dec 31, 2023 | 676 | -43 | -5.98% |
| Dec 31, 2022 | 719 | -43 | -5.64% |
| Dec 31, 2021 | 762 | 262 | 52.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 222 |
| Genfit | 188 |
| Innate Pharma | 174 |
| Transgene | 147 |
| MedinCell | 145 |
| DBV Technologies | 117 |
| Nanobiotix | 103 |
| Inventiva | 84 |
Valneva SE News
- 3 days ago - Valneva sees lower 2026 sales as third-party revenue winds down - Seeking Alpha
- 3 days ago - Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook - GlobeNewsWire
- 9 days ago - Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom - GlobeNewsWire
- 16 days ago - VALNEVA Declaration of shares and voting rights: January 31, 2026 - GlobeNewsWire
- 19 days ago - Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ® - GlobeNewsWire
- 4 weeks ago - Valneva, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 4 weeks ago - Valneva Withdraws Chikungunya Vaccine IXCHIQ Applications In U.S. Amid FDA Suspension - Nasdaq
- 4 weeks ago - Valneva (VALN) Withdraws Chikungunya Vaccine Applications in the U.S. - GuruFocus